Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Exelon, Nivalin, Rivastigmina
Rivastigmine is a cholinesterase inhibitor used to treat mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease dementia. It works by increasing the levels of acetylcholine, a neurotransmitter important for memory and learning, in the brain. Rivastigmine is available in various formulations, including capsules, oral solution, and transdermal patches.
For the treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease dementia.
Outcome:
Reduced effectiveness of rivastigmine
Mechanism:
Pharmacodynamic antagonism
Outcome:
Increased risk of gastrointestinal bleeding
Mechanism:
Additive effects on gastric mucosa
Outcome:
Delayed absorption
Mechanism:
Food may affect absorption rate
Most likely new formulation: Extended-release oral formulation (2025, 75% confidence)
Based on current usage trends and clinical trial data, there is a 90% likelihood that rivastigmine will maintain its current regulatory status for the next 5 years.
Cholinesterase Inhibitor, Dementia Medication
Carbamate